With the analysis among 404 patents, we discovered top 48 key players by total patent application. Vaccinex, Inc., Sumitomo Pharmaceuticals Co., Ltd., Boehringer Ingelheim International GmbH are dominant in this area. They take 48.76% of the total patent filing.
New York, United States
Patent: 99
Osaka-fu, Japan
Patent: 66
Rheinland-Pfalz, Germany
Patent: 32
Washington, United States
Patent: 23
Washington, United States
Patent: 9
Massachusetts, United States
Patent: 8
Basel-Stadt, Switzerland
Patent: 7
California, United States
Patent: 7
With the analysis among 10 patents, we discovered top 1 start-ups by total patent application.
With the analysis among related 125 patents applied in the last 5 years. We discover 31 most active companies in this area. The fast-growing Vaccinex, Inc., Boehringer Ingelheim International GmbH, Merck KGaA take 71.20% of patent filing during this period.
New York, United States
Patent: 56
Rheinland-Pfalz, Germany
Patent: 27
Tennessee, United States
Patent: 4
Kanagawa-ken, Japan
Patent: 2
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 2
With the analysis among related 125 patents in last 5 years, we discover 18 new entrants. Merck KGaA, Ramot at Tel Aviv University Ltd., H. Lee Moffitt Cancer Center & Research Institute, Inc. are the most active new entrants in this area.
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 2
Massachusetts, United States
Patent: 2
Shaanxi Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among 177 patents, we discovered top 30 universities and scientific research institutions by total patent application. Keio University, Yokohama City University, Vlaams Instituut voor Biotechnologie - Flanders Institute are dominant in this area. They take 31.64% of the total patent filing.
Tokyo-to, Japan
Patent: 15
Kanagawa-ken, Japan
Patent: 11
British Columbia, Canada
Patent: 8
North Carolina, United States
Patent: 7
ZURICH, Switzerland
Patent: 5
Connecticut, United States
Patent: 4